Correction: Liu, H.W.; et al. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 2019, 11, 1888

Heng-Wei Liu; Peter Mingjui Lee; Oluwaseun Adebayo Bamodu; Yu-Kai Su; Iat-Hang Fong; Chi-Tai Yeh; Ming-Hsien Chien; I-Hung Kan; Chien-Min Lin

doi:10.3390/cancers12102846

Correction: Liu, H.W.; et al. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 2019, 11, 1888

Cancers (Basel). 2020 Oct 1;12(10):2846. doi: 10.3390/cancers12102846.

Authors

Heng-Wei Liu^{1

2

3

4}, Peter Mingjui Lee⁵, Oluwaseun Adebayo Bamodu^{4

6

7}, Yu-Kai Su^{1

2

3

4}, Iat-Hang Fong^{3

4}, Chi-Tai Yeh^{1

4

6

7

8}, Ming-Hsien Chien¹, I-Hung Kan^{1

2

3

4}, Chien-Min Lin^{1

2

3

4}

Affiliations

¹ Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
² Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
³ Division of Neurosurgery, Department of Surgery, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.
⁴ Taipei Neuroscience Institute, Taipei Medical University, Taipei 11031, Taiwan.
⁵ Department of Clinical Oncology, College of Medicine, California North state University, Elk Grove, California, CA 95757, USA.
⁶ Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan.
⁷ Department of Medical Research and Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 235, Taiwan.
⁸ Department of Medical Laboratory Science and Biotechnology, Yuanpei University of Medical Technology, Hsinchu City 30015, Taiwan.

Abstract

The authors wish to make the following corrections to this paper [...].

Publication types

Published Erratum